経口固形製剤受託製造の市場規模、シェア、動向分析レポート：製品別、メカニズム別、最終用途別、地域別、セグメント予測、2025年～2030年

経口固形製剤受託製造市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の経口固形製剤受託製造の市場規模は2030年までに547億2,000万米ドルに達し、2025年から2030年までのCAGRは5.99％を記録すると推定されています。

新薬分子の複雑化、大手CMOやCDMOによる研究開発投資、新規治療に対する需要の高まりが市場成長を促進する主な要因です。

経口固形製剤は、コスト効率が高く、製造が簡単で患者に優しいため、医薬品分野で広く受け入れられている剤形です。さらに、放出制御や徐放形成などのドラッグデリバリー技術の進歩により、経口固形製剤は薬剤投与回数を減らしながら、さらに高いレベルのバイオアベイラビリティを達成できるようになっています。これにより、市場成長の可能性が促進されると予想されます。

経口固形製剤の開発と大量製造における技術の進歩は、これらの製品の迅速な商業化を支える主な要因の一つです。現在、市場では多様な剤形が入手可能です。しかし、栄養補助食品業界と製薬業界は一貫してOSD剤形の開発に力を入れています。その理由は、取り扱いが容易で、摂取が便利で、患者の服薬アドヒアランスが良好なためです。OSD製剤の技術や材料の進歩が見込まれ、これらの製剤の需要を押し上げると予測されています。

さらに、CMOやCDMOによる研究開発投資は、製造プロセス、製剤開発、分析技術における技術革新の強化に貢献しています。これは、経口固形製剤の製造において、より効率的で高度な製造技術の採用につながる可能性があります。また、研究開発への投資は製造能力の拡大と拡張性の向上につながります。これによりCMOやCDMOは、製薬会社からの需要の増加に対応するため、より大量の経口固形製剤を提供できるようになります。

さらに、この業界では2023年に、提携、パートナーシップ、M&A、サービス拡大など、多くの戦略的な動きが見られました。

• 2023年7月、Aenova GroupとGalvitaは、経口剤の製剤化、生産、開発を改善するための戦略的パートナーシップを締結しました。
• 2023年4月、Aenovaがティットモニングにある固形製剤の大量生産拠点を拡張するために約2,196万米ドル（2,000万ユーロ）を投資し、生産能力を増強しました。
• 2023年1月、CatalentとEthicannは、口腔内崩壊錠（ODT）技術として知られるCatalentの技術を使用してEthicannの臨床医薬品パイプラインを開発するために提携しました。

経口固形製剤受託製造市場レポートハイライト

• 2024年の売上高シェアは錠剤セグメントが32.74%で市場を独占しました。錠剤は、費用対効果、コンパクト性、製造の容易さ、自己投与の利便性から、最も一般的で好まれるOSD形態です。二層錠に対する需要の増加と、製剤化および放出制御錠剤製造の拡大のための企業による投資が、市場成長の原動力になると予測されます。
• 放出制御錠剤セグメントは2024年に最大のシェアを占めました。この成長は、ドーム錠、二剤式錠剤、腸管パッチ、ポリマーナノシステム、正確な薬物送達のためのエクソソームなどのバイオインスパイアされた送達方法など、経口放出制御デリバリーシステムの進歩によるものです。このように、放出制御剤形に対する需要の高さが、近い将来のセグメント収益成長を押し上げると予想されます。
• 最終用途に基づくと、大規模企業セグメントが2024年に最大のシェアを占めました。固形製剤製造市場は、連携、柔軟性、高い適応性によってますます定義されるようになっています。医薬品を最初から設計し、大手CMOに委託することを意図する製薬開発企業が増えており、それによって市場の成長が加速しています。さらに、経口固形製剤を専門とするCMOは、大手製薬企業にいくつかのメリットを提供できるため、採用が増加しています。
• アジア太平洋は2024年に世界市場をリードし、予測期間中に最も速いCAGRを記録すると予測されています。中国とインドは、経口固形製剤受託製造の強国であり、価格も大幅に安いです。さらに、シンガポール、インド、韓国などのアジア諸国では、製造能力の拡大により、製薬業界の主要プレーヤーと見なされています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• テクノロジー情勢
  • 製造技術
  • カプセル化技術
  • コーティング技術
  • 包装技術
  • 分析技術
• 価格モデル分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 経口固形製剤受託製造市場：製品推定・動向分析

• セグメントダッシュボード
• 経口固形製剤受託製造市場：製品変動分析
• 経口固形製剤受託製造の規模と動向分析（製品別、2018年～2030年）
• タブレット
• カプセル
• 粉末
• 顆粒
• その他

第5章 経口固形製剤受託製造市場：メカニズム推定・動向分析

• セグメントダッシュボード
• 経口固形製剤受託製造市場：メカニズム変動分析
• 経口固形製剤受託製造の規模と動向分析（メカニズム別、2018年～2030年）
• 即時放出
  • 遅延放出
  • 制御放出

第6章 経口固形製剤受託製造市場：最終用途推定・動向分析

• セグメントダッシュボード
• 経口固形製剤受託製造市場：最終用途変動分析
• 経口固形製剤受託製造の規模と動向分析（最終用途別、2018年～2030年）
• 大企業
• 中規模・小規模企業
• その他

第7章 経口固形製剤受託製造市場：地域別ビジネス分析

• 地域ダッシュボード
• 市場規模・予測と動向分析、2018年～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業分類
• 企業市況分析、2024年
• 企業プロファイル
  • Catalent, Inc.
  • Lonza
  • Aenova Group
  • Boehringer Ingelheim International GmbH
  • Jubilant Pharmova Limited
  • Patheon Pharma Services
  • Recipharm AB.
  • Corden Pharma International
  • Siegfried Holding AG
  • Piramal Pharma Solutions
  • AbbVie Contract Manufacturing
  • Next Pharma AB

List of Tables

• Table 1 List of abbreviations
• Table 2 North America Oral Solid Dosage Contract Manufacturing Market, by Region, 2018 - 2030 (USD Million)
• Table 3 North America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 4 North America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 5 North America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 6 U.S. Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 7 U.S. Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 8 U.S. Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 9 Canada Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 10 Canada Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 11 Canada Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 12 Mexico Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 13 Mexico Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 14 Mexico Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
• Table 16 Europe Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 17 Europe Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 18 Europe Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 UK Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 20 UK Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 21 UK Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 22 Germany Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 23 Germany Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 24 Germany Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 25 France Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 26 France Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 27 France Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 28 Italy Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 29 Italy Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 30 Italy Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 31 Spain Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Spain Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 33 Spain Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 34 Denmark Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 35 Denmark Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 36 Denmark Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 37 Sweden Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 38 Sweden Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 39 Sweden Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 40 Norway Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 41 Norway Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 42 Norway Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 47 China Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 48 China Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 49 China Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 50 India Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 51 India Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 52 India Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 53 Japan Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 54 Japan Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 55 Japan Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 56 Australia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 57 Australia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 58 Australia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 59 South Korea Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 60 South Korea Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 61 South Korea Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 62 Thailand Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 63 Thailand Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 64 Thailand Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
• Table 66 Latin America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Latin America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 68 Latin America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Brazil Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 70 Brazil Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 71 Brazil Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 72 Argentina Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 73 Argentina Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 74 Argentina Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
• Table 76 MEA Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 77 MEA Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 78 MEA Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 South Africa Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 80 South Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 81 South Africa Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 85 UAE Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 86 UAE Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 87 UAE Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 88 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 89 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
• Table 90 Kuwait Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Oral solid dosage contract manufacturing market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Commodity flow analysis
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD model sizing & forecasting
• Fig. 10 Market formulation & validation
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Parent market outlook, 2024 (USD Million)
• Fig. 16 Ancillary market outlook, 2024 (USD Million)
• Fig. 17 Oral solid dosage contract manufacturing market dynamics
• Fig. 18 Product approvals in the U.S. and EU per year (2024)
• Fig. 19 Porter's five forces analysis
• Fig. 20 PESTEL analysis
• Fig. 21 Oral solid dosage packaging types in the U.S., 2024 (volume percentage share %)
• Fig. 22 Oral solid dosage blister packaging types in the U.S., 2024 (volume percentage share %)
• Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
• Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
• Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
• Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
• Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
• Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
• Fig. 37 Large size companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Medium & small size companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Regional market: Key takeaways
• Fig. 41 Regional outlook, 2024 & 2030
• Fig. 42 Regional outlook, 2024 & 2030
• Fig. 43 North America market, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 UK oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 France oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 China oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
• Fig. 70 India oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Clinical trial authorization process in Japan
• Fig. 73 Clinical Research of Medical Products in Japan
• Fig. 74 Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 78 Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Clinical trial approval process in South Korea
• Fig. 81 South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Clinical trial authorization process UAE
• Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Key country dynamics
• Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)

Oral Solid Dosage Contract Manufacturing Market Growth & Trends:

The global oral solid dosage contract manufacturing market size is estimated to reach USD 54.72 billion by 2030, registering a CAGR of 5.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.

• In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
• In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
• In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

• The tablets segment dominated the market with a revenue share of 32.74% in 2024. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth.
• The controlled release segment accounted for the largest share in 2024. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future.
• Based on end-use, the large size companies segment accounted for the largest share in 2024. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption.
• Asia Pacific led the global market in 2024 and is projected to witness the fastest CAGR over the forecast period. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Top Down Market Estimation (Model 2)
  • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
  • 1.5.4. Multivariate Analysis (Model 4)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
    • 3.3.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
    • 3.3.1.3. Increasing Demand for Novel Therapies
    • 3.3.1.4. Increasing Demand for One-Stop-Shop CMOs
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Strict Approval Criteria by Regulatory Authorities
    • 3.3.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
    • 3.3.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
• 3.4. Technology Landscape
  • 3.4.1. Manufacturing Technology
  • 3.4.2. Encapsulation Technology
  • 3.4.3. Coating Technology
  • 3.4.4. Packaging Technology
  • 3.4.5. Analytical Technology
• 3.5. Pricing Model Analysis
• 3.6. Industry Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Oral Solid Dosage Contract Manufacturing Market; Product Movement Analysis
• 4.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Tablets
  • 4.4.1. Tablets market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Capsules
  • 4.5.1. Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Powders
  • 4.6.1. Powders market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Granules
  • 4.7.1. Granules market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Oral Solid Dosage Contract Manufacturing Market; Mechanism Movement Analysis
• 5.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
• 5.4. Immediate Release
  • 5.4.1. Immediate release market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Delayed Release
    • 5.4.2.1. Delayed release market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Controlled Release
    • 5.4.3.1. Controlled release market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Oral Solid Dosage Contract Manufacturing Market; End Use Movement Analysis
• 6.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Large Size Companies
  • 6.4.1. Large size companies market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Medium & Small Size Companies
  • 6.5.1. Medium & small size companies market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Regional Business Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Mexico oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. UK oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. France oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. China oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. India oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Brazil oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Argentina oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. South Africa oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Saudi Arabia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. UAE oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Kuwait oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Company Profiles
  • 8.3.1. Catalent, Inc.
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Service benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Lonza
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Service benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Aenova Group
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Service benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Boehringer Ingelheim International GmbH
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Service benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Jubilant Pharmova Limited
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Service benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Patheon Pharma Services
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Service benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Recipharm AB.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Service benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Corden Pharma International
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Service benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Siegfried Holding AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Service benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Piramal Pharma Solutions
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Service benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. AbbVie Contract Manufacturing
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Service benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Next Pharma AB
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Service benchmarking
    • 8.3.12.4. Strategic initiatives